Literature DB >> 2883607

Pain management after lower extremity amputation.

R P Iacono, J Linford, R Sandyk.   

Abstract

Phantom pain may occur in up to 85% of patients after limb amputation. Although the pathophysiology of postamputation phantom pain is not well understood, it seems to be produced by a complex multifactorial interaction between the peripheral, sympathetic, and central nervous systems. The theoretical aspects of this are reviewed. Management of phantom limb pain may be both medical and surgical. Among the pharmacological agents proved effective against phantom pain are beta-blockers, tricyclic antidepressants, and anticonvulsants. Surgical management includes peripheral nerve stimulation, thermocontrolled coagulation of the spinal cord, spinal cord stimulation, transcutaneous nerve stimulation, and stereotactic deep brain stimulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2883607     DOI: 10.1227/00006123-198703000-00027

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

Review 1.  Peripheral nerve stimulation for neuropathic pain.

Authors:  Konstantin V Slavin
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

2.  Anxiety and depression in patients with amputated limbs suffering from phantom pain: a comparative study with non-phantom chronic pain.

Authors:  Hadi Kazemi; Shahin Ghassemi; Seyed Mohammad Fereshtehnejad; Afshin Amini; Pier Hossein Kolivand; Taher Doroudi
Journal:  Int J Prev Med       Date:  2013-02

3.  Postamputation pain: epidemiology, mechanisms, and treatment.

Authors:  Eugene Hsu; Steven P Cohen
Journal:  J Pain Res       Date:  2013-02-13       Impact factor: 3.133

4.  Usefulness of milnacipran in treating phantom limb pain.

Authors:  Yasuhide Nagoshi; Akira Watanabe; Saiko Inoue; Tomoki Kuroda; Mitsuo Nakamura; Yoshitake Matsumoto; Kenji Fukui
Journal:  Neuropsychiatr Dis Treat       Date:  2012-11-20       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.